Andrew
CEO - UK - iCEO #32876

Experience

Experienced CEO/COO/CCO highly adept at developing an effective vision, mission, and strategy for business growth; aligning, empowering, and supporting teams to deliver on that shared purpose; and providing the seasoned leadership critical to maximize operational effectiveness and exceed performance targets.

Major Achievements

Drove negotiations and sale of company in January 2021 at above-industry multiples and led establishment of a new consulting division, which leveraged the companies’ combined strategic product development and regulatory strategy consulting capabilities in assisting biopharmaceutical companies and delivered >€20 mio new business. Engineered a full-scale turnaround of company business whilst guiding organisation through the sudden death of its founder/chief science officer and the subsequent absence of its CEO (who was the CSO’s spouse). Drove YoY growth, delivering record increases of 20% and 30%, respectively, in revenue and profitability in 2020; grew 2021 revenue another 15% and raised EBITDA 82%. Figured prominently in raising company valuation for lucrative sale in 2021. Built an effective governance framework, with board and major investors, which was struggling to achieve agreed value inflection milestones.

Industry Sector Competencies

BioTech

Genetics

Pharmaceutical

Consumer Goods

Medical Equipment

Professional Objectives

Function: C-Suite (CEO, MD, COO, CCO, CBO)

Sector: Biotech, Life Sciences, pharmaceutical, consumer health

Interim Manager: Yes

Permanent Position: Yes

Operational: Yes

Availability: Full time

Prefered Locations: Not Africa or Russia

Additional Professional Interests

Non executive director assignments

Personal financial investment: 150-350K USD

Countries Covered

Australia

Malaysia

New Zealand

Singapore

UK

Operational Competencies

Technologies to market (Professional)

Business development (Expert)

New product or service launch (Expert)

Geographical expansion (Expert)

Company rescue or turnaround (Expert)

Close down or sell off (Expert)

Pre or post investment audit (Professional)